News Releases

Philly Police Now Transport 2 of Every 3 Gunshot Victims to Hospital

January 25, 2021

Twice as many patients are now brought to trauma centers by police, with survival rates comparable to those transported by EMS professionals, according to a new study from researchers at the Perelman School of Medicine at the University of Pennsylvania who examined five years of data.

Emergency Medicine

Opiate Overdoses Spike in Black Philadelphians, But Drop in White Residents Since COVID-19

January 21, 2021

While it has been reported that opioid overdose deaths have increased during the COVID-19 pandemic, a new study looking at data in Philadelphia showed that this hardship has been overwhelmingly suffered by Black individuals.

Emergency Medicine

Patients in Cancer Remission at High Risk for Severe COVID-19 Illness

January 21, 2021

Patients with inactive cancer and not currently undergoing treatments also face a significantly higher risk of severe illness from COVID-19, a new study from Penn Medicine published online today in JNCI Cancer Spectrum shows.

Cancer

Mutations Commonly Linked to Breast Cancer Found to Pose No Increased Risk, Population Study Reveals

January 20, 2021

Several genetic mutations previously linked to breast cancer and included on commercial genetic tests, including direct-to-consumer tests, were found not to increase a woman’s risk of disease, according to a population study of more than 64,000 women published online today in the New England Journal of Medicine from several institutions, including Penn Medicine.

Cancer

Penn Study Shows Outcomes of Critically Ill COVID Patients Improved Consistently During the Pandemic

January 19, 2021

Despite unchanging patient characteristics and severity of COVID-19, mortality rates for critically ill patients treated in the ICU for the virus progressively declined over time during the first surge of the pandemic, according to researchers in the Perelman School of Medicine at the University of Pennsylvania. The study suggests that clinicians and hospital staff rapidly improved their approach to managing the novel disease even before widespread use of evidence-based medications. The findings are published in the Annals of Internal Medicine.

COVID-19

Discovery Could Lead to More Effective PARP Inhibitor Drugs Against Cancer

January 18, 2021

PARP inhibitors are recently developed drugs that have shown great promise against some types of ovarian, breast, prostate and pancreatic cancer, but many patients’ tumors develop resistance to the drugs. Now researchers at the Perelman School of Medicine at the University of Pennsylvania have reported a strategy for defeating such resistance and boosting the effectiveness of these drugs.

Cancer

COVID-19 Variant B.1.1.7 Found in Southeast Pennsylvania

January 15, 2021

Evidence of infection by the highly transmissible B.1.1.7 variant of the COVID-19 coronavirus first identified in the United Kingdom has been found in a southeast Pennsylvania resident.

COVID-19

Penn Physicist, Physician Team Awarded $2 Million NIH Grant to Develop Portable COVID-19 Detector for Use in Public Spaces

January 14, 2021

A team led by physicists at the University of Pennsylvania and physicians at the University’s Perelman School of Medicine has been awarded a two-year, $2 million grant by the National Institutes of Health (NIH) National Center for Advancing Translational Sciences for the development of a handheld device that can detect the signature “odor” of people with COVID-19, the illness caused by the coronavirus SARS-CoV-2.

COVID-19

Awards and Accolades: December 2020

January 14, 2021

Learn how Penn clinicians and researchers are being honored by their peers.

Award

New Treatment Target Discovered That Halts Osteoarthritis-Like Knee Cartilage Degeneration

January 14, 2021

There is currently no cure for osteoarthritis, but a group of scientists believe they’ve discovered a method through which a simple knee injection could potentially stop the disease’s effects. These researchers showed that they could target a specific protein pathway in mice, put it into overdrive and halt cartilage degeneration over time. Building on that finding, they were able to show that treating mice with surgery-induced knee cartilage degeneration through the same pathway via the state of the art of nanomedicine could dramatically reduce the cartilage degeneration and knee pain.

Orthopaedics and Musculoskeletal

Browse By:

Philly Police Now Transport 2 of Every 3 Gunshot Victims to Hospital

January 25, 2021

Opiate Overdoses Spike in Black Philadelphians, But Drop in White Residents Since COVID-19

January 21, 2021

Patients in Cancer Remission at High Risk for Severe COVID-19 Illness

January 21, 2021

Mutations Commonly Linked to Breast Cancer Found to Pose No Increased Risk, Population Study Reveals

January 20, 2021

Penn Study Shows Outcomes of Critically Ill COVID Patients Improved Consistently During the Pandemic

January 19, 2021

Discovery Could Lead to More Effective PARP Inhibitor Drugs Against Cancer

January 18, 2021

COVID-19 Variant B.1.1.7 Found in Southeast Pennsylvania

January 15, 2021

Penn Physicist, Physician Team Awarded $2 Million NIH Grant to Develop Portable COVID-19 Detector for Use in Public Spaces

January 14, 2021

Awards and Accolades: December 2020

January 14, 2021

New Treatment Target Discovered That Halts Osteoarthritis-Like Knee Cartilage Degeneration

January 14, 2021

Contacts